These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25838639)

  • 1. Pivotal roles of GM-CSF in autoimmunity and inflammation.
    Shiomi A; Usui T
    Mediators Inflamm; 2015; 2015():568543. PubMed ID: 25838639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF Biology.
    Hamilton JA; Anderson GP
    Growth Factors; 2004 Dec; 22(4):225-31. PubMed ID: 15621725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF in inflammation and autoimmunity.
    Hamilton JA
    Trends Immunol; 2002 Aug; 23(8):403-8. PubMed ID: 12133803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Seymour JF
    Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of granulocyte-macrophage colony-stimulating factor.
    Fleetwood AJ; Cook AD; Hamilton JA
    Crit Rev Immunol; 2005; 25(5):405-28. PubMed ID: 16167889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
    Sheng G; Chen P; Wei Y; Chu J; Cao X; Zhang HL
    Respir Res; 2018 Aug; 19(1):163. PubMed ID: 30165864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice.
    Shiomi A; Usui T; Ishikawa Y; Shimizu M; Murakami K; Mimori T
    J Immunol; 2014 Jul; 193(2):849-59. PubMed ID: 24951817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
    Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
    N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
    Däbritz J
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GM-CSF in inflammatory and autoimmune disorders.
    Achuthan AA; Lee KMC; Hamilton JA
    Semin Immunol; 2021 Apr; 54():101523. PubMed ID: 34776300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor.
    Zhan Y; Xu Y; Lew AM
    Mol Immunol; 2012 Aug; 52(1):30-7. PubMed ID: 22580403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
    Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-GM-CSF autoantibodies (GM-CSF autoantibodies)].
    Watanabe M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():684-6. PubMed ID: 20942163
    [No Abstract]   [Full Text] [Related]  

  • 17. GM-CSF as a therapeutic target in inflammatory diseases.
    van Nieuwenhuijze A; Koenders M; Roeleveld D; Sleeman MA; van den Berg W; Wicks IP
    Mol Immunol; 2013 Dec; 56(4):675-82. PubMed ID: 23933508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GM-CSF in lung balance and disease.
    Chen Y; Li F; Hua M; Liang M; Song C
    Front Immunol; 2023; 14():1158859. PubMed ID: 37081870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF alters dendritic cells in autoimmune diseases.
    Li BZ; Ye QL; Xu WD; Li JH; Ye DQ; Xu Y
    Autoimmunity; 2013 Nov; 46(7):409-18. PubMed ID: 23786272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticytokine autoantibodies in infection and inflammation: an update.
    Barcenas-Morales G; Jandus P; Döffinger R
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):523-529. PubMed ID: 27755185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.